Page 334 - Williams Hematology ( PDFDrive )
P. 334

308  Part IV:  Molecular and Cellular Hematology        Chapter 21:  Dendritic Cells and Adaptive Immunity            309




                  CD1c. CD1d molecules on DCs also efficiently present the synthetic   DENDRITIC CELL SUBSETS
                                         31
                  glycolipid  α-galactosylceramide.  This process leads to activation of
                                                                    32
                  distinct lymphocytes with a restricted T-cell repertoire, the NKT cells.    The primary function of DCs is to survey host tissues and initiate
                  NKT cells have significant potential as effector cells because they can   responses  upon encountering  danger  signals.  To  optimally  perform
                  produce large amounts of interferon-γ and lyse tumor targets.  these functions, DCs are present in every tissue of the body, and are
                     A newer “nonclassical” pathway for antigen presentation involves   enriched  in  lymphoid  tissues.  Immature  DCs  are  strategically  posi-
                                                            33
                  presentation of “endogenous” proteins on MHC class II.  This path-  tioned along body surfaces (skin, airway, gut) and in the interstitial
                  way involves autophagy and is also well developed in DCs.  It allows   spaces of many organs, such as the heart and kidneys. DCs are able to
                                                             34
                  nuclear, mitochondrial and cytoplasmic proteins to be presented from   extend their processes through the tight junctions in epithelia, without
                  digestive compartments, including as a first example, the Epstein-Barr   altering the epithelial barrier, allowing them to sample antigens from
                  nuclear antigen 1. 35                                 harmless environmental antigens and commensal microorganisms. In
                                                                        the steady state, DCs migrate continuously from tissues into afferent
                                                                        lymphatics and probably blood. By electron microscopy, DCs in lym-
                  MATURATION OF DENDRITIC CELLS                         phoid tissues often are termed interdigitating cells, appearing as large
                  Immature DCs efficiently take up antigen but do not induce immunity,   stellate cells with a lucent “empty”-appearing cytoplasm.
                  defined as the production of immune effectors and the establishment   One method of categorizing DCs is to describe them based upon
                  of memory. For immune induction to occur, DCs require additional   the tissue in which they reside. Lymphoid tissue–resident DCs have
                  stimuli that lead to an intricate differentiation process called “matura-  undergone intensive study, especially in murine models. The scarcity of
                  tion.” Maturation involves changes in endocytic and antigen processing   DCs in nonlymphoid tissues, on the other hand, limited understanding
                  machineries, production of chemokines and cytokines, and expression   of their importance for many years and continues to render study of
                  of many cell-surface molecules, including those of the B7, TNF, and   these cells challenging. Because circulating DCs are the most accessible
                  Notch ligand families.  DCs  have an endocytic  system that is tightly   subset in humans, they have received intense study; however, blood DCs
                  regulated and devoted to presentation of captured antigens, rather than   may not reflect accurately the biology of tissue resident cells. Briefly, all
                  clearance and scavenging.                             DCs subsets are CD45+CD11c+class II+ cells that lack markers associ-
                     In the case of DCs derived from marrow and monocyte precursors,   ated with T-cell, B-cell, erythroid, granulocytic, and NK lineages. How-
                  DC maturation is accompanied by exquisite changes in the endocytic   ever, such a definition is not complete as some macrophages express this
                  system with attendant consequences for antigen processing and presen-  phenotype yet are distinct from the DC lineage. Additional confidence
                  tation. During maturation, antigen uptake is dampened as a result of   in a DC lineage is provided by expression of Flt-3 (FMS-like tyrosine
                  inactivation of a rho-guanosine triphosphatase termed cdc42.  At the   kinase 3, CD135), which mediates signals important in the differentia-
                                                               36
                  same time, machinery associated with antigen processing is augmented.   tion of this lineage, c-kit and/or CCR7.
                  Lysosomal  processing  is  activated  by assembly  of  an  active  proton   An alternative method for classifying DC subsets separates the major
                  pump, which acidifies the lysosome so that processing of antigens and   lineages as classical dendritic cells (cDCs) versus plasmacytoid dendritic
                  the MHC class II associated invariant chain can proceed. MHC–peptide   cells (pDCs). cDCs are the most plentiful and incorporate lymphoid
                  complexes form within the endocytic system of the maturing DCs, 37,38    tissue–resident and nonlymphoid tissue–resident DCs. Although both
                  then traffic in distinct nonlysosomal compartments to the cell surface.   pDCs and cDCs derive from a common progenitor, pDCs are distinct
                  Internalization and degradation of MHC II also occurs via ubiquitina-  from cDCs in appearance (they resemble plasma cells) and they reside pri-
                  tion is also inhibited in mature DCs.  DC maturation also increases   marily in blood and lymphoid tissue, but are not found in nonlymphoid
                                             39
                  presentation on MHC I via, in part, the formation of an “immunopro-  tissues. pDCs are important mediators of innate immunity, because of
                  teasome,” a combinatorial form of proteasome that increases the spec-  their capacity to rapidly produce high levels of interferon (IFN)−α upon
                  trum of peptides destined to be presented on MHC I. 40  encounter with pathogens that engage the TLR-7 and TLR-9 receptors,
                     A hallmark of  DC maturation in response to  several  stimuli  is   which are plentiful in this subset. cDCs are frequently further subdivided
                  upregulation of costimulatory molecules such as CD80 and CD86,   into lymphoid-resident cDCs versus nonlymphoid-resident cDCs. In
                  resulting at least in part from production of inflammatory cytokines,   mice, most lymphoid-resident cDCs are CD8α+CD11b− whereas most
                  particularly TNF-α.  Importantly however, CD86 upregulation should   nonlymphoid-resident cDCs are CD103+CD11b−. CD8α+CD11b−
                                32
                  not be equated directly with immune activation, which requires other   lymphoid tissue–resident cDC have a similar origin, phenotype, and
                  DC functions, such as those triggered by CD40 ligation, including pro-  transcriptional profile as CD103+CD11b− nonlymphoid-resident
                  duction of cytokines such as IL-12 or type I interferons, and/or engage-  cDC. In contrast, CD11b+ cDCs can be found in both lymphoid and
                  ment of other receptors such as CD70. 32              nonlymphoid tissue, and this subset is notable for its ability to derive
                     DCs enhance antibody formation by several mechanisms. The   from monocytes in response to granulocyte-monocyte colony-stimu-
                  classical pathway involves induction of antigen-specific CD4+ helper   lating factor (GM-CSF), monocyte colony-stimulating factor (M-CSF),
                  T cells, which then help B-cell growth and antibody secretion. How-  and other  inflammatory  mediators. CD8α+ and CD8α− cDCs show
                  ever, DCs can also directly affect B cells to enhance immunoglobulin   a remarkable division of labor in terms of the nature of induced host
                  (Ig) secretion and isotype switching, including production of the IgA   response. While CD8α+ DCs efficiently cross-prime CD8+ T-cell
                  class of antibodies, which contribute to mucosal immunity. 41,42  DCs can   immunity through MHC class I antigen presentation,  CD8α− DCs
                                                                                                                45
                  induce a B-cell class switch in a CD40-independent manner, through   stimulate predominantly CD4+ T-cell response through MHC class II
                  production of ligands such as B-lymphocyte stimulator (B-cell activat-  presentation.  These differences may be explained in part by the fact
                                                                                  46
                  ing factor belonging to the TNF family [BAFF]) and a proliferation-   that CD8α+ DCs have high endosomal pH, low antigen degradation,
                  induced ligand (APRIL), including T-cell–independent induction of   high antigen export to cytosol, and more presynthesized stores of MHC
                  IgA antibodies to commensal organisms.  Plasmacytoid DCs stimulate   class I molecules. 47,48
                                               43
                  antibody responses to influenza virus in culture.  Production of anti-  In humans, essentially all DCs lack lineage markers for T
                                                     44
                  bodies by any of these mechanisms may lead to interaction with DC   cells, B cells, NK cells, and erythroid and granulocytic lineages,
                  FcγR and thereby an adaptive response by T cells.     and express CD45 and MHC class II. Human pDCs are described as






          Kaushansky_chapter 21_p0307-0312.indd   309                                                                   9/17/15   5:52 PM
   329   330   331   332   333   334   335   336   337   338   339